Showing results (841-850 of 996) with videos related to
Sort By:
Pageof 100
Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.International Journal of Molecular Sciences|September 14, 2024
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma PatientsDomenico Mallardo, Mario Fordellone, Andrew White, et al.Journal of Translational Medicine|September 8, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapyDomenico Mallardo, Mario Fordellone, Andrew White, et al.Journal of Inherited Metabolic Disease|July 3, 2010
Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophyOsvaldo Artigalás, Valeska Lizzi Lagranha, Maria Luiza Saraiva-Pereira, et al.BMC Psychiatry|April 16, 2020
Clinical effectiveness of a web-based peer-supported self-management intervention for relatives of people with psychosis or bipolar (REACT): online, observer-blind, randomised controlled superiority trialFiona Lobban, Nadia Akers, Duncan Appelbe, et al.American Journal of Clinical Pathology|October 6, 2005
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS casesRobert P Gormley, Rashna Madan, Alina E Dulau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2022
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classificationD Trapani, M A Franzoi, H J Burstein, et al.Health Education Research|July 31, 2016
Asthma self-management model: randomized controlled trialCarolina M X Olivera, Elcio Oliveira Vianna, Roni C Bonizio, et al.Therapeutic Advances in Medical Oncology|March 26, 2021
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapyMorena Fasano, Carminia Maria Della Corte, Giuseppe Viscardi, et al.Cancer|November 2, 2021
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse eventsEdward H Ip, Santiago Saldana, Kathy D Miller, et al.Pageof 100